CURX — Curanex Pharmaceuticals Share News
0.000.00%
Last trade - 00:00NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Curanex Pharmaceuticals Advancing Phyto-N Toward A Planned Investigational New Drug Submission To FDA For Ulcerative Colitis In Q4 2026
Brief: Curanex Pharmaceuticals Expands Drug Development Pipeline
Brief: Curanex Pharmaceuticals Inc - Targets Ind Submission For Phyto-N In Q4 2026
Brief: Curanex Provides Operational Update On Key Regulatory Milestones
Brief: Curanex Pharmaceuticals Inc. Announces Closing Of Its Initial Public Offering
Brief: Curanex Pharmaceuticals Announces Pricing Of Its Initial Public Offering
Brief: Curanex Pharmaceuticals Says Now Sees IPO Of Up To 5.5 Million Shares Of Common Stock